San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, AllStripes Research is raising $45,199,734.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Nancy Yu played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About AllStripes Research
AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. AllStripes has developed a technology platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data. AllStripes was founded by CEO Nancy Yu and technology developer Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2. The company is backed by Lux Capital, JAZZ Venture Partners, Spark Capital, Medidata Solutions, McKesson Ventures, Maveron, and a number of angel investors.

To learn more about AllStripes Research, visit http://www.allstripes.com/

Contact:
Nancy Yu, President and Chief Executive Officer
408-596-1386
nancy@allstripes.com
https://www.linkedin.com/in/yunancy/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved